The technology powering Therapy Performance Management™
ReX® combines a connected medication device with a cloud-based intelligence platform to make therapy performance visible, actionable, measurable, and provable.
A fill confirms that medication was dispensed. It does not confirm whether it was taken as intended, what the patient experienced during therapy, whether emerging risks were visible, or whether an intervention changed what happened next. Without direct visibility, adherence, patient experience, intervention impact, and therapy performance must largely be inferred.
Was the medication taken as intended?
Refill data confirms medication availability. It does not confirm dosing behavior.What was the patient experiencing during therapy?
Side effects, symptoms, and treatment barriers may not surface until the next refill or clinical visit, if they surface at all.Were early signs of discontinuation visible?
Changes in dosing behavior, symptoms, and engagement may emerge before the patient stops therapy.Did the right intervention happen in time, and did it work?
Outreach may occur, but the intervention and what happened afterward are rarely connected in one measurable record.The ReX® creates direct visibility into what previously could not be seen.
ReX supports the prescribed therapy schedule, captures patient interactions, and connects independently to the ReX Cloud Platform. No phone, application, pairing, or home Wi-Fi is required.
The ReX® Cloud Platform connects dosing behavior with patient-reported context captured by the ReX device and applies configurable rules, thresholds, and pattern recognition to identify changes that may require attention.
These therapy signals help specialty pharmacies recognize emerging risk while there is still an opportunity to support the patient and maintain therapy continuity.
A signal creates value only when the right team can act on it. ReX® provides the specialty pharmacy with the relevant dosing behavior and patient context behind each signal, enabling more timely and targeted intervention.
ReX® Therapy Intelligence Platform provides a continuously updated view of how therapy is performing. This allows programs to identify what is working, where performance is being lost, and where support strategies can be improved.
96% confirmed dosing.
88% ePRO response rate captured at each dose.
Patients staying on therapy longer, +10% at 12 months.
Reduced by 40-55% at 6 months.
Because confirmed dosing and patient context are connected throughout the therapy journey, ReX® creates a more complete and defensible view of therapy performance. This creates a real-world evidence asset that helps explain how therapy performed, what influenced that performance, and which interventions made a measurable difference.
One connected record of how therapy performed, what influenced it, and which interventions made a measurable difference.
Start seeing what others miss. Therapy performance becomes visible, actionable, and measurable.